Crossmark

Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13075-019-1886-y

Published Online: 2019-04-24

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frecklington, Mike https://orcid.org/0000-0002-5457-5235
Dalbeth, Nicola

McNair, Peter

Morpeth, Trish

Vandal, Alain C.

Gow, Peter

Rome, Keith
License Information

Text and Data Mining valid from 2019-04-24
More Information

Article History

Received: 5 December 2018

Accepted: 1 April 2019

First Online: 24 April 2019

Ethics approval and consent to participate

: The trial was approved by the New Zealand Ministry of Health, Health and Disability Ethics Committees (14/CEN/117) and all participants provided written informed consent.

: Not applicable.

: N. D. has received consulting fees, speaker fees or grants from Takeda, Teijin, Menarini, Amgen, Ardea Biosciences, AstraZeneca, Horizon, Cymabay and Kowa, outside the submitted work. K. R. has received funding from ASICS, outside the submitted work. ASICS had no role in the design of the study. The footwear used in the study was purchased at retail price. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.